CQY Capital

CQY Capital is a private equity investment fund management company based in Pudong, China, established in August 2016. The firm is led by a diverse founding team with expertise in real estate, healthcare, construction, finance, and the entertainment industry. Currently managing 5 billion yuan, CQY Capital focuses on investments in healthcare, TMT (technology, media, and telecommunications), fintech, and cultural sectors. Notable investments include projects in the film industry and a leading allergen detection equipment company in the healthcare sector. In 2017, CQY Capital also launched a significant cinema acquisition fund. The firm aims to broaden its investment portfolio by exploring opportunities in securities investment, mezzanine financing, mergers and acquisitions, and wealth management, positioning itself as an emerging player in China's financial landscape.

Xiao Han

Founding Partner

Shuyang Ni

Co-Founding Partner and President

Zheng Wang

Founding Partner and CEO

Ming Zhu

Partner

6 past transactions

DeePoon

Venture Round in 2022
DeePoon VR develops head mounted devices as well as VR content. DeePoon’s technology is supported on both PC and mobile platforms. Its VR content distribution platform 3Dbobo has accumulated more than 1.5 million users, according to the company. The company’s valuation has now reached USD 830 million. They landed USD 30 million from download manager Xunlei and mobile game developer Kingnet in Series B financing in December 2015. DeePoon will be able to use Xunlei’s technology in its content distribution network and cooperate with Kingnet to develop VR games. Animation and culture company Alpha also invested in the company and became its strategic partner at the end of last year to further collaborate in animation production, film production and game development. DeePoon’s main products include the Virglass series and E series VR helmets, which feature Active Matrix/Organic LED (AMOLED) display screens.

Zhongze Therapeutics

Seed Round in 2022
Zhongze Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies for psychiatric and neurological disorders. The company aims to address unmet medical needs in the central nervous system (CNS) by creating transformative drug candidates that provide effective treatment options for patients suffering from these conditions. Through its focused research and development efforts, Zhongze Therapeutics seeks to advance new therapies that can significantly improve patient outcomes in the realm of CNS diseases.

DeePoon

Series E in 2021
DeePoon VR develops head mounted devices as well as VR content. DeePoon’s technology is supported on both PC and mobile platforms. Its VR content distribution platform 3Dbobo has accumulated more than 1.5 million users, according to the company. The company’s valuation has now reached USD 830 million. They landed USD 30 million from download manager Xunlei and mobile game developer Kingnet in Series B financing in December 2015. DeePoon will be able to use Xunlei’s technology in its content distribution network and cooperate with Kingnet to develop VR games. Animation and culture company Alpha also invested in the company and became its strategic partner at the end of last year to further collaborate in animation production, film production and game development. DeePoon’s main products include the Virglass series and E series VR helmets, which feature Active Matrix/Organic LED (AMOLED) display screens.

MicroPort Orthopedics

Private Equity Round in 2020
MicroPort Orthopedics is a producer of orthopedic products and a member of the MicroPort Scientific Corporation family of companies. Its knee and hip implants are constantly being improved just as medical procedures. It operates as a start-up of an industry powerhouse. This is critical to achieving its goal of being the growing, innovation-driven company in orthopedics. Their top priority isn’t just to help surgeons get patients back to their feet. The Arlington, Tennessee-based company in 2014.

Linmon Pictures

Series C in 2018
Linmon Pictures is an independent entertainment studio based in China, specializing in the creation, production, and distribution of drama series. With a focus on high-quality content, the company has developed a reputation for producing premium drama series that attract significant viewership. Linmon Pictures leverages its extensive library of original intellectual properties to develop engaging stories that resonate with audiences. The majority of its revenue is generated within Mainland China, reflecting its strong presence and influence in the local entertainment market.

Motie.com

Series C in 2017
Motie.com, based in Beijing, China, operates as a book publishing company that provides comprehensive publishing services. The company focuses on connecting writers and authors across various fields, aiming to offer a diverse range of creative themes and innovative books to its clients. Additionally, Motie.com manages several digital reading platforms, enhancing the accessibility of literature and catering to the evolving preferences of readers in the digital age. Through its initiatives, the company seeks to refresh the publishing landscape by promoting new voices and ideas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.